Immediate Impact

2 from Science/Nature 62 standout
Sub-graph 1 of 23

Citing Papers

Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
2024 Standout
2 intermediate papers

Works of Jun Sakata being referenced

Valproic acid overcomes transforming growth factor-β-mediated sorafenib resistance in hepatocellular carcinoma.
2014
Surgical Outcomes for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
2011

Author Peers

Author Last Decade Papers Cites
Jun Sakata 449 459 259 411 61 963
Fuyo Yoshimi 477 451 312 397 60 1.1k
Christian Wittekind 529 330 227 411 43 1.0k
Takafumi Kumamoto 543 583 288 458 78 1.1k
Keun Soo Ahn 641 468 315 489 66 1.1k
Masayoshi Yoshimori 403 447 326 397 41 1.1k
Paolo Massucco 528 698 349 343 36 1.1k
Shun‐ichi Ariizumi 688 404 388 323 66 1.0k
Martha M. Kirstein 407 368 261 480 64 1.1k
Yoshihito Kotera 543 366 206 431 51 898
L Hafström 361 565 264 414 60 1.1k

All Works

Loading papers...

Rankless by CCL
2026